Usingtwo-dimensional electrophoresis, we mapped boththe total and the cytoskeletalproteinsof human plateletsbefore and after activation with thrombin or the calcium ionophore A23187. Activation resulted in increased abundance of the phosphorylated form of myosin light chains with an approximate molecular mass of 20 kDa, decreased abundance of two proteins with molecular masses of approximately 18 and 25 kDa, and, in the case of activation with thrombin, the appearance of a new chain of protein spots (named "Thromb:1 "). The latter, found associated with isolated detergent-insoluble cytoskeletons, reacted with antibody to human fibrinogenand thus were identifiedas y-y dimers of fibrin. The total numberof proteinsassociatedwiththe cytoskeleton increasedafteractivationwith eitherthrombinor A23187, but we observedsome differencesin which proteins were bound, and for how long.
Ca2 -dependent forms (11).
The phosphorylated form of the myosin light chain has ATPase activity that can be activated by actin (12) , and the phosphorylated myosin light chain is selectively isolated with detergent-insoluble cytoskeletons prepared from thrombin-activated platelets (5). Fox and Phillips (5) suggested that, because adenosine diphosphate (ADP) does not cause phosphorylation of myosin light chains under conditions where secretion is inhibited (i.e., no fibrinogen or Ca2) but phosphorylation does occur along with secretion, the phosphorylation of the 20-kDa myosin light chain and subsequent actin-myosin interaction is a requisite for secretion (5).
The increased association of myosin (in the phosphorylated form) with the cytoskeleton of activated platelets is accompanied by an increase in the overall protein content of cytoskeleton preparations (3, 13, 14). Using one-dimensional electrophoresis, Phillips et al. demonstrated that the detergent-resistant cytoskeletons of unstimulated platelets contained primarily actin, actin binding protein, a 255-kDa protein, and a small amount of myosin (13) . Cytoskeletons prepared from thrombin-activated platelets, however, contained higher concentrations of actin, myosin, actin binding protein, and the 225-kDa protein than did the control, plus many other, more minor peptides. Electron microscopy revealed that the cytoskeletons from unstimulated platelets looked like actin ifiaments, while those from thrombinactivated platelets looked like organized structures that had been extracted intact from individual platelets (13). Other than studies on the reversible association of myosin, little attention has been paid to the increased, although transient, association of a seemingly specialized population of proteins with the cytoskeletons during platelet activation.
Fox et al. (15) recently published the results of a study in which they used two-dimensional electrophoresis to analyze the protein changes that occur after platelets are activated. Their results included those for proteins, from whole homogenate preparations, with relative molecular masses >4A) 000. In the present study, we used two-dimensional electrophoresis with an acrylamide gradient in the second dimension that allowed a wider range of molecular mass to be seen, and we examined both total and cytoskeletal proteins from resting and activated human platelets. By using thrombin and the calcium ionophore A23 187, we have been able to describe activator-specific protein changes in the platelet protein population and have found that different proteins are associated with the cytoskeleton of activated platelets, depending on the activator used for stimulation.
Our two-dimensional electrophoresis patterns also show how much more complex the cytoskeletal protein population of activated platelets is relative to resting platelets, and we provide some additional identification of the proteins associated with the cytoskeleton.
Materials and Methods

Isolation of platelets.
For each experiment, 250 mL specimens of human blood were obtained from Hinsdale Hospital after collection during leukophoresis.
Acid-citrate-dextrose was used as the anticoagulant during blood collection, and we added two tubes of'l'hrombotect" (Abbott Laboratories; 100 x 16 mm tubes) to each 250-mL specimen before we began to isolate platelets. "Platelet-rich" plasma was prepared by centrifuging the blood at 500 x g for 15 mm. Platelets were then concentrated from the plasma by centrifugation at 800 x g for 20 mm. The resulting pellet of platelets was suspended in 20 vol of pH 6.5 buffer containing, per liter, 113 mmol of NaC1, 4.3 mmol of K2HPO4, 4.3 mmol of Na21{P04, 24.4 mmol of Na2HPO4, 55 minol of glucose, 1.5 mmol of adenosine, and 1 mmol of theophylline (16) We dissolved pellets containing activated or non-activated platelets (approximately 0.1-mL packed cell volume) in 0.5 mL of a solution containing, per liter, 9 mol of urea, 40 mL of Nonidet P40 surfactant (NP4O), 20 mL of 2-mercaptoethanol, and 100 mL LKB Ampholines (pH 9-li; stock concentration 20% by weight),adjusted to pH 95 with NaOH ("NP4O-urea mix").
We used 10 to 20 L of each sample for two-dimensional electrophoresis gels, which we stained with Coomassie Brilliant Blue. For gels that were to be stained with silver, each sample was diluted with an equal volume of the same NP4O-urea mixture and 5-10 pL was used per gel. (17) . After resuspension was complete, an additional 9 mL of the buffer was added. The detergent-resistant cytoskeleton material was collected by centrifugation for 1 h at 70 000 X g. Cytoskeleton pellets were dissolved in 0.25 mL of NP4O-urea, and 10 to 20 L of each sample was subjected to twodimensional electrophoresis, and the gels were stained with Coomassie Brilliant Blue (5-10 tzL of samples diluted 1:1 with additional NP4O-urea was used on gels to be stained with silver).
tric focusing was done as previously described (18) with LKB ampholytes (75 pL of pH 2.5-4 plus 675 tL of pH 3.5-9.5). After equilibration with sodium dodecyl sulfate (SDS) (19), proteins were separated in the second-dimension by SDS-polyacrylainide gel electrophoresis (SDS-PAGE) on slab gels that were linear gradients of polyacrylamide, 90-280 g/ L. Details of the 81)8-PAGE procedures were as previously described (20) . Slab gels were fixed and stained in Coomassie Blue solutionas before (21) or were fixed for at least 4 h in a solution containing, per liter, 500 mL of ethanol with 1 mL of formaldehyde and stained with silver according to the method of Guevara et al. (22) , with use of half the amount of citric acid and formaldehyde described in that paper for development.
Immunochemical staining.
Proteins with homogenates of human plateletsthat were thrombin-activated 
Protein identification.
We identified the myosin heavy chains, actin, and a-actinin by co-migration with a homogenate of human skeletal muscle in which the positions of the major contractile and structural proteins have been previously identified (24) . Gelsolin was identified by co-migration with purified gelsolin (a gift from Dr. K. Okuda, Osaka City Medical School, Osaka, Japan) and also by comparison with the published identification of Fox et al. (15) . The platelet tropomyosins were identified by their co-purification in nonmuscle tropomyosin preparations done according to Fine et al. (25) , their shift to a higher apparent relative molecular mass when the second dimension separation was done in the presence of urea (26), and their reactivity with antibodies to tropomyosin (27) . Myosin light chains were identified by their migration pattern, which was similar to that of myosin preparations from human fibroblasts (unpublished data). Tubulin and the subunits of fibrinogen were identified by staining nitrocellulose transfers to two-dimensional gels with specific antisera (23) . Albumin was identified by comigration with human plasma (28). batch of thrombin used) and increased in abundance up to 60 mm, the longest interval we studied. Thromb:1 migrates to the same approximate position as a-actimn in the twodimensional gel system used; therefore it has an SDSmolecular mass of approximately 100 000 (30). The cytoskeleton preparations from control platelets contained a few major proteins-including actin, tubulin, aactinin, and tropomyosin-plus a small population of unidentified proteins, present in low abundance, and a trace amount of the myosin light chains. After a short incubation with thrombin, however, a more complex pattern of proteins associated with the cytoskeleton appeared ( Figure IF) . The myosin light chains, fibrinogen subunits, gelsolin, and several poorly resolved, high-Mr proteins (large arrows pointing up in Figure 1 , F-H) were more prominent than in the control. In addition, several proteins not seen at all in the control cytoskeletons were associated with the platelet cytoskeleton after brief exposure to thrombin. These included the 25-kfla protein described above in the total plateletprotein analysis, which decreases in abundance after throm- However, a few, including Thromb:1, the fibrinogen subunits, and gelsolin, remained associated at concentrations exceeding the comtrol after 20 mmof incubation with thrombun. The amount of a-actunin associated with the cytoskeleton appeared to remain the same throughout the period of thrombin incubation studied.
Results
Activation
of platelets with the calcium ionophore A23187 resulted in some of the same changes in the protein patterns found after incubation with thrombin (Figure 2; patterns similar to those shown in panels D and H were obtained after 5-, 10-, and 20-mm incubations).
A quantitative increase in the phosphorylated form of the myosin light chains was obvious just 1 mm after A23187 was added ( Figure 2B ). The abundance of the 18-and 25-kDa proteins decreased, also by 1 mm.Thromb:1 did not appear, however, even after incubation for 60 mm.As in the case of thrombin activation, the increased abundance of the phosphorylated myosin light chains was transient, with a return to control levels by 30 mm after the A23187 was added. The abundance of the 18-and 25-kDa proteins was unchanged, well below that of the control, after 30 mm of incubation with A23187 ( Figure 2C ) and at 60 minutes ( Figure 2D) .
As with platelets activated by thrombin, more proteins were found associated with the cytoskeletons prepared from platelets incubated with A23187 for 1 mm than with those prepared from control platelets (Figure 2, E-F) . The proteins more abundant in cytoskeletons of A23187-treated platelets included a-actimn, gelsolin, the myosin light chains, several poorly resolved high-Mr proteins that are as yet unidentified (large arrows in Figure 2F ), and the 25-kDa protein that showed a decreased abundance in the wholeprotein pattern. Unlike the case of thrombin-activated platelets, in the 423187-activated platelets the association of all of these proteins was transient (Figure 2, G-Ji) . Thirty mmutes after the ionoph&re was added ( Figure 2G ) the cytoskeleton protein pattern was identical to that of the control. Also in contrast to the thrombin-activated platelets, the A23187-activated platelets showed no increased association of the fibrinogen subunits with the cytoskeleton, even after 60 mm of incubation with the ionophore.
Activation of platelets with ADP (0.1 zmol per liter of incubation medium) and collagen (20 pg per milliliter of incubation medium) also failed to stimulate the appearance of Thromb:1 (data not shown), although the increase in the phosphorylated form of the myosin light chains and the decrease in the 18-and 25-kDa protein were observed. Enlargement of (he Thromb:1 region from Figure 1 , A-D, shows the charge and molecular-mass heterogeneity of this protein set (Figure 3) . When a nitrocellulose transfer of the protein pattern shown in Figure ID 
Discussion
Two-dimensional electrophoretic patterns of total proteins from platelets activated with either thrombin or A23187 differed in three ways from patterns for unactivated platelets: (a) new protein spots appeared (e.g., Thromb:1), (b) some proteins increased in abundance (e.g., the phosphorylated form of myosin light chains), and (c) some decreased in abundance (e.g., the 18-and 25-kDa proteins). Except for Thromb:1, which appeared only when thrombin was used, thrombin and A23187 caused the same changes in the total protein pattern. The increased abundance of the phosphorylated form of the myosin light chains we observed is in agreement with results of other investigators, who used onedimensional electrophoresis (5). The decreased abundance of the 18-and 25-kDa proteins, previously unreported, could be due to activation of a specific protease during the platelet activation process or to the secretion of those particular proteins from the platelets as part of the secretion process associated with platelet activation.
Phillips et al. (13) reported previously that the amount of detergent-insoluble material increased when platelets were activated before extraction, and others have confirmed this observation (3, 14) . Using two-dimensional electrophoresis to resolve the proteins, we also found that the number of proteins associated with the cytoskeleton was greater for platelets activated with thrombin or A23187 than for control platelets. Because staining with silver is approximately 100 times more sensitive than staining with Coomassie Blue for detection of protein in polyacrylamide gels (31), we have been able to show more proteins, even in the control platelet preparations, than have been described previously (3, 13, 14) . Unlike the platelet cytoskeleton preparations described by Rosenberg et al. 33) and to the fact that we isolated the cytoskeletons at room temperature rather than on ice [microtubules dissociate in the cold (33)1. In addition to tubulin, our control platelets contained tropomyosin, actin, a-actinin, a small amount of gelsolin and myosin (both heavy and light chains), and approximately 50 other unidentified proteins in various abundances. Activation by either thrombin or A23 187 caused an increase in the number of proteins associated with the cytoskeleton, but there were differences in the specific proteins that became associated and differences in the duration of their association. The amount of fibrinogen associated with the cytoskeletons was increased by thrombin but not A23187, and Thromb:1 appeared only after activation with thrombin.
Fox et al. (15) also reported the appearance of a protein with a molecular mass similar to Thromb:1 (peptide 4, ref.
15) after activation with thrombin, and suggested that it was the y-y dimer of fibrin. Our data showing the specific reactivity of Thromb:1 with antibody to fibrinogen confirms that suggestion. The association of the fibrinogen subunits with the cytoskeleton and the fact that Thromb:1 did not appear after activation with A23187, ADP, or collagen suggest that thrombin causes the specific binding of fibrinogen to the platelet cytoskeleton and subsequent conversion to fibrin. There is evidence that fibrinogen is present both in surface-associated form and intracellularly in platelets, and that the intracellular fibrinogen is released from a-granules after platelet activation as part of the secretory response or A23187. These proteins were not generated if EGTA or inhibitors of calcium-dependent proteases such as leupeptin were included in the reaction mixture, which led them to suggest that these proteins were the products of the calcium-dependent protease activated during platelet aggregation. We failed to find any of the three peptides described 5 mmolJL) for the activation reaction. The theophylline keeps platelets from being "spontaneously" stimulated before thrombin or A23187 is added. Perhaps this alteration of conditions caused the Ca2-dependent protease to remain inactive. A notable difference between the activation of platelets with thrombin and A23187 is the longevity of the association of specific proteins with the cytoskeleton. Cytoskeletons prepared from platelets that were activated with thrombin showed a constant level of associated a-actinin, comparable to the control, throughout the incubation period studied.
Cytoskeletons
prepared from platelets activated with A23187 for 1 mm, however, showed a definite increase in the amount of associated a-actinin, with a decrease to control levels after longer periods of incubation. Rosenberg et al. (32) reported that the association of a-actimn with the platelet cytoskeleton is Ca2 tdependent. Therefore the obvious increase in a-actinin association with the cytoskeleton after treatment with A23 187 could be a result of an sudden increase in cytosol Ca2 concentration owing to the activity of the calcium ionophore. Thrombin activation also alters the intracellular Ca2 concentration, but probably through interaction with membrane receptors and a second-messenger mechanism rather than directly as with A23 187.
We observed an increase in the phosphorylated form of three myosin light chain proteins with molecular masses of approximately 20 kDa (approximate difference among the three is 500 Da) in the two-dimensional electrophoretic patterns of total proteins from platelets activated for just 1 mm with either thrombin or A23 187. Previous investigators have reported that platelet myosin contains two 20-kDa light chains (36) and that these light chains can be phosphorylated (10). Pollard et al. (36) , however, showed a small peak that eluted between the 20-kDa and 15-kDa myosin light chains on gel filtration, suggesting the possibility of an additional myosin subunit. Therefore, our observation of three myosin light chains with molecular masses all near 20 kDa is most probably attributable to the superior resolution of our two-dimensional gel system. As reported by others using one-dimensional electrophoresis techniques (5), the phosphorylation of the myosin light chains was directly correlated with the increased association of the myosin (both heavy and light chains) with the cytoskeleton. The myosin light chains were partly dephosphorylated, however, during our cytoskeleton preparation procedure, as shown by the decreased abundance of the more-acidic forms in the cytoskeleton patterns as compared with the total protein patterns of proteins isolated after one mmute of activation (Figure 1, B and F; Figure 2, B and F) .
Inclusion of sodium fluoride to inhibit phosphatase activity protected the myosin light chains from dephosphorylation, but decreased the amount of myosin associated with the cytoskeleton as well (data not shown). A similar decrease in association of myosin was observed by Fox and Phillips (5), who used a combination of potassium phosphate, sodium pyrophosphate, and sodium molybdate as phosphatase inhibitors. Our purpose was to evaluate the proteins associated with the cytoskeleton after activation of platelets, so we decided to eliminate phosphatase inhibitors from the preparation buffer in order to obtain more nearly complete cytoskeletal protein populations at the expense of preserving the phosphorylated form of the myosin light chains.
We did not find the P47 protein, which is reportedly phosphorylated in platelets after activation with thrombin and is thought to play a role in secretion of platelet granules (6, 8) . The obvious phosphorylation of the myosin light chains in our study serves as a control, showing that the expected effects of activation did occur. P47 has apI between 6.0 and 6.5(8) and an approximate Mr of 40-47 kDa (2, 6, 8, 14) , depending on the SDS electrophoresis system used for analysis. Therefore this protein may not have been resolved from actin in our patterns. Imaoko et al. (8) showed that P47 stains very faintly relative to actin with Coomassie Brilliant Blue, and therefore would be easily overpowered by the high concentration of actin in the preparations we analyzed. This study has shown that different substances that activate platelets can cause some specific differences in the proteins that are associated with the cytoskeleton, and in the duration of those protein associations. More studies are needed to test the effects of other activators such as ADP, collagen, and ristocetin, in order to unravel the various mechanisms of these different effects and perhaps to provide information on the identity of the proteins that become associated transiently with the cytoskeleton. This report represents the beginning of a data base on normal platelet proteins that will continue to grow as more studies are done. The long-term objectives are to explain protein alterations due to diseases affecting platelets in the context of the normal protein population and to describe the molecular events occurring after activation or treatment with drugs.
